ChemSensing customizes chemically reactive dyes, to include metalloporphyrins, that form the core of our technology.
- Arrays of these reactive dyes undergo measurable color change when they are exposed to volatile organic compounds and other gases.
- ChemSensing measures these color changes to produce clustered data that generates definitive results.
- The arrays are unaffected by humidity and have excellent chemical/thermal stability.
- ChemSensing is an expert at customizing these arrays by changing the chemical structure of the reactive dyes.
- These changes allow the arrays to be tuned to specific volatile organic compounds and applications.
ChemSensing is developing non-invasive diagnostic tests for a variety of disease states:
- R&D strategy has resulted in a significant opportunity in early stage disease detection with markedly reduced result times and costs, particularly in the arenas of bacterial infections and lung cancer.
- The Company leverages its capabilities by collaborating with leading biomedical research institutions including Cleveland Clinic Foundation, Case Western Reserve University, and University of Pennsylvania Hospital.
- The Company's proximity to the University of Illinois at Urbana-Champaign provides access to world class minds and resources.
